EQS-News: BitFrontier Capital Holdings, Inc. (OTC: BFCH) Appoints Dr. Jordan P. Balencic as CEO to Lead Strategic Corporate Turnaround

CRESTVIEW, FL - July 24, 2025 (NEWMEDIAWIRE) - BitFrontier Capital Holdings, Inc. (OTC: BFCH), a public company historically engaged in cryptocurrency mining and hosting services, today announced the appointment of Dr. Jordan P. Balencic as its Chief Executive Officer. This leadership transition marks the beginning of a comprehensive turnaround strategy aimed at realigning the Company’s capital structure, business model, and shareholder value proposition.

Dr. Balencic is a physician entrepreneur and public company advisor with over a decade of experience in the health and wellness industry. He has served on the boards of other OTC and small-cap issuers and brings expertise in governance, strategic pivots, capital formation, and investor engagement. He is also the founder of EVERMIND™, a plant-based cognitive health beverage brand supported by emerging neuroscience.

“When I evaluated BFCH, I saw a solid reset opportunity - a clean public company with no litigation, minimal overhead, and the flexibility to move fast,” said Dr. Balencic. “We’re executing on a plan to eliminate legacy overhang, streamline the share structure, and shift into a high-growth sector with meaningful long-term potential.”

Strategic Plan Underway

Under Dr. Balencic’s leadership, BFCH intends to pursue the following strategic actions, subject to corporate and regulatory approvals:

• Debt Elimination: The Company is taking steps to retire over $2 million in legacy convertible note obligations. These instruments have historically contributed to significant dilution pressure. Their removal is expected to materially improve the Company’s capital structure and equity profile.
  
  
• Business Model Pivot: BFCH is developing a new operating strategy focused on consumer health innovation, targeting opportunities in:
  • Functional foods, nootropic beverages, and supplements
  • Food and beverage manufacturing infrastructure
  • Digital health and wearable technologies
  • AI-driven cognitive assessment tools and coaching
  • Early-stage health-tech acquisitions and brand incubation
    
    
• Corporate Rebrand: A full rebranding initiative is underway to reflect the Company’s new strategic focus. Additional details will be announced following internal approvals and regulatory notifications.
  
  
• Capital Structure Optimization: BFCH plans to streamline its share structure and reduce its authorized share count, with the objective of improving equity efficiency and preparing for future capital formation.
  
  
• Governance Reform: A new Board of Directors is being assembled to support the Company’s transition and bring industry expertise aligned with the Company’s renewed mission.
  
  
• OTCQB Uplisting Intent: BFCH intends to pursue OTCQB qualification in 2026, which will require completion of a PCAOB audit, maintenance of current public disclosures, and meeting all eligibility criteria. The Company views OTCQB status as a key milestone in building investor confidence and expanding access to institutional capital.

All material updates will be published through the OTC Markets Disclosure & News Service and in compliance with applicable securities laws.